These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 24217122

  • 1. Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.
    Tsai WC, Peng YS, Yang JY, Hsu SP, Wu HY, Pai MF, Chang JF, Chen HY.
    Blood Purif; 2013; 36(2):116-21. PubMed ID: 24217122
    [Abstract] [Full Text] [Related]

  • 2. Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.
    Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Baños A, Zani V, Fouque D.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2852-9. PubMed ID: 19369690
    [Abstract] [Full Text] [Related]

  • 3. Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism.
    Kovacevic B, Ignjatovic M, Zivaljevic V, Cuk V, Scepanovic M, Petrovic Z, Paunovic I.
    Langenbecks Arch Surg; 2012 Mar; 397(3):413-20. PubMed ID: 22240976
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
    Zhang Y, Lu Y, Feng S, Zhan Z, Shen H.
    Ren Fail; 2019 Nov; 41(1):921-929. PubMed ID: 31573378
    [Abstract] [Full Text] [Related]

  • 5. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
    Zhang L, Yao L, Hua Z, Bian WJ, Li WG.
    Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
    [Abstract] [Full Text] [Related]

  • 6. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Jul; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 7. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
    Yamada S, Taniguchi M, Tokumoto M, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2010 Aug 01; 14(4):424-31. PubMed ID: 20649764
    [Abstract] [Full Text] [Related]

  • 8. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients.
    Gagné ER, Ureña P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C, Drüeke TB.
    J Am Soc Nephrol; 1992 Oct 01; 3(4):1008-17. PubMed ID: 1450363
    [Abstract] [Full Text] [Related]

  • 9. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul 01; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

  • 10. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D, Racasan S, Kacso IM, Rusu C, Potra A, Bondor C, Patiu IM, Gherman-Căprioară M.
    Int Urol Nephrol; 2015 Nov 01; 47(11):1871-7. PubMed ID: 26377492
    [Abstract] [Full Text] [Related]

  • 11. [CA-P control in haemodialysis and K/DOQI guidelines].
    Rivera F, Sánchez de la Nieta MD, Echarri R, Anaya S, Carreño A, Vozmediano MC, Alcaide MP.
    Nefrologia; 2006 Nov 01; 26(3):351-7. PubMed ID: 16892824
    [Abstract] [Full Text] [Related]

  • 12. Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
    Lomonte C, Antonelli M, Losurdo N, Marchio G, Giammaria B, Basile C.
    Nephrol Dial Transplant; 2007 Jul 01; 22(7):2056-62. PubMed ID: 17449495
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism.
    Tsai WC, Peng YS, Chiu YL, Wu HY, Pai MF, Hsu SP, Yang JY, Tung KT, Chen HY.
    Int Urol Nephrol; 2015 Jul 01; 47(7):1203-7. PubMed ID: 26025063
    [Abstract] [Full Text] [Related]

  • 14. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
    Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB.
    Surgery; 2018 Feb 01; 163(2):381-387. PubMed ID: 29146232
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
    Zitt E, Rix M, Ureña Torres P, Fouque D, Jacobson SH, Pétavy F, Dehmel B, Ryba M.
    Nephrol Dial Transplant; 2011 Jun 01; 26(6):1956-61. PubMed ID: 20947534
    [Abstract] [Full Text] [Related]

  • 16. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun 01; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 17. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
    Lucchi L, Carboni C, Stipo L, Malaguti V, Ferrari F, Graziani R, Arletti S, Graziosi C.
    Artif Organs; 2011 Dec 01; 35(12):1186-93. PubMed ID: 21848793
    [Abstract] [Full Text] [Related]

  • 18. Hyperparathyroidism: a seven-year follow-up.
    Juergensen PH, Cooper K, Kliger AS, Finkelstein FO.
    Adv Perit Dial; 1998 Dec 01; 14():188-90. PubMed ID: 10649721
    [Abstract] [Full Text] [Related]

  • 19. Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.
    Oltmann SC, Madkhali TM, Sippel RS, Chen H, Schneider DF.
    J Surg Res; 2015 Nov 01; 199(1):115-20. PubMed ID: 25982045
    [Abstract] [Full Text] [Related]

  • 20. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC, Ma WY, Yu JC, Wu CC, Chu P.
    Clin Endocrinol (Oxf); 2012 May 01; 76(5):634-42. PubMed ID: 22007930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.